Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | BUB1 | O43683 | 1/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5207833 | 0.86 | HDAC1 (0.51) | HDAC1HDAC6KDM4ESMN1; SMN2 | |
| SCHEMBL6689321 | 0.84 | HDAC1 (0.42) | HDAC1HDAC6KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL6774729 | 0.84 | HDAC1 (0.45) | HDAC1HDAC6KDM4EALDH1A1TSHR | |
| SCHEMBL6694051 | 0.83 | HDAC1 (0.44) | HDAC1HDAC6KDM4EALDH1A1HPGD | |
| SCHEMBL6693115 | 0.83 | FABP3 (0.45) | HDAC1HDAC6KDM4EALDH1A1HSD17B10 | |
| SCHEMBL6691476 | 0.83 | KDM4E (0.46) | HDAC1HDAC6KDM4EALDH1A1HSD17B10 | |
| SCHEMBL6691242 | 0.82 | HDAC1 (0.46) | HDAC1HDAC6KDM4EPLA2G2AMAPT | |
| SCHEMBL6689259 | 0.82 | HDAC1 (0.40) | HDAC1HDAC6KDM4EALDH1A1HSD17B10 | |
| SCHEMBL6693538 | 0.82 | HDAC1 (0.42) | HDAC1HDAC6KDM4EALDH1A1HSD17B10 | |
| SCHEMBL6775399 | 0.82 | PLA2G2A (0.42) | HDAC1HDAC6BUB1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0952149-B1 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors | LILLY CO ELI (US) | 2004-06-09 | — | — | EP | disclosed |
| US-6713645-B1 | INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK | ELI LILLY AND COMPANY | 2004-03-30 | — | — | US | disclosed |
| US-6177440-B1 | THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR | ELI LILLY AND COMPANY | 2001-01-23 | — | — | US | disclosed |
| EP-0952149-A2 | Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors | ELI LILLY AND COMPANY (US) | 1999-10-27 | — | — | EP | disclosed |